UPDATE : Monday, September 7, 2020
상단여백
Will Biogen win FDA nod for Alzheimer’s drug aducanumab?
Biogen has filed for U.S. approval for its investigational Alzheimer’s dise...
by Kim Yun-mi  |  2020-07-09 16:06
라인
Regulator to reclassify dermatological cream Lidomex as prescription drug
The drug regulator said it would reclassify dermatological treatments, incl...
by Kim Yun-mi  |  2020-07-08 11:24
라인
‘Study results on MSD’s Keytruda very disappointing’
Local experts expressed dissatisfaction with MSD’s Keynote-604 trial result...
by Kim Yun-mi  |  2020-07-07 16:43
라인
Experts showed mixed preferences between 2 diabetes treatments
Two classes of drugs -- sodium-glucose cotransporter-2 (SGLT2) inhibitors a...
by Kim Yun-mi  |  2020-07-06 14:20
라인
MSD Korea reshuffles personnel before spinoff of Organon
MSD Korea has newly appointed key executives to lead each business unit bef...
by Kim Yun-mi  |  2020-07-02 13:44
라인
[Special] HIV patients pushed aside amid Covid-19 crisis
The Covid-19 pandemic prompted the public health authorities to concentrate...
by Kim Yun-mi  |  2020-07-01 16:18
라인
Hanmi, Novartis in patent dispute over diabetes drug
A court is to decide on the legal dispute between Hanmi Pharmaceutical and ...
by Kim Yun-mi  |  2020-06-25 13:59
라인
Labor-management dispute runs deep at MSD Korea
The conflict between unionized workers and management at MSD Korea is inten...
by Kim Yun-mi  |  2020-06-23 12:06
라인
RIGHT Fund adds ₩18 billion to support for infectious disease research
The Research Investment for Global Health Technology (RIGHT) Fund said it w...
by Kim Yun-mi  |  2020-06-22 17:22
라인
‘Pfizer’s Vyndaqel, Vyndamax do not deserve rare disease pricing’
Pfizer’s Vyndaqel and Vyndamax -- containing tafamidis to treat cardiomyopa...
by Kim Yun-mi  |  2020-06-22 17:19
라인
New diabetes drug Steglatro fails to prove cardiovascular benefit
Steglatro (ingredient: ertugliflozin), the latecomer sodium-glucose co-tran...
by Kim Yun-mi  |  2020-06-19 14:55
라인
AZ’s Imfinzi wins extra indication for small-cell lung cancer
AstraZeneca’s immunotherapy Imfinzi (ingredient: durvalumab) has obtained l...
by Kim Yun-mi  |  2020-06-18 15:55
라인
Lilly beats Pfizer in treating early breast cancer
Pfizer was the first to release a drug for the treatment of hormone recepto...
by Kim Yun-mi  |  2020-06-18 14:44
라인
‘Tecentriq, major turning point for triple-negative breast cancer treatment’
Roche Korea’s Tecentriq, the first immunotherapy to win indication for trip...
by Kim Yun-mi  |  2020-06-18 14:43
라인
IOF aims to reduce osteoporosis-related fractures by 25% by 2025
The International Osteoporosis Foundation, a non-governmental organization ...
by Kim Yun-mi  |  2020-06-17 14:28
라인
Regulator to discuss re-evaluation of choline alfoscerate
The Ministry of Food and Drug Safety said it would discuss whether to re-as...
by Kim Yun-mi  |  2020-06-17 12:36
라인
‘Celltrion has no reason to save Takeda Korea workers’ jobs’
Takeda Pharmaceutical’s sell-off of part of its business to Celltrion is ex...
by Kim Yun-mi  |  2020-06-16 11:44
라인
Jardiance family of diabetes drugs sells ₩10 billion in Q1
The Jardiance family of diabetes drugs, including Jardiance (empagliflozin)...
by Kim Yun-mi  |  2020-06-15 17:39
라인
Biogen’s FDA application for Alzheimer’s drug drags on
Biogen’s filing of aducanumab, an investigational Alzheimer’s drug, for U.S...
by Kim Yun-mi  |  2020-06-15 12:09
라인
Immunotherapies potent on rare small-cell lung cancer, biliary tract cancer
Latest oncology studies have proved that immunotherapies were effective on ...
by Kim Yun-mi  |  2020-06-12 12:03
-12345678910-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top